ApaTech, a world leader in applying the science of silicon to bone graft technology, announced the global launch of ActifuseTM MIS. The unique, purpose designed applicator provides unprecedented access to the graft site for surgeons performing open and minimally invasive procedures and who require a synthetic bone graft ready for immediate use.
Actifuse MIS is ideal for use in a range of spine and orthopedic procedures including posterolateral fusion, tumor/bone void filling and acetabular cysts. The applicator facilitates controlled bone graft delivery through flexible 20cm x 0.8cm prefilled cartridges for fast and precise graft placement.
Actifuse Advanced Bone matriX (ABX) is 96% granules and can be placed straight into the operative site without the need to be mixed with blood or bone marrow aspirate.The unique, silicate substituted, calcium phosphate chemistry of Actifuse is a significant advance in synthetic bone graft technology providing:
• An optimized, osteostimulative scaffold that enhances bone formation
• A safe and effective alternative to both autograft and allograft.
• Steady and predictable remodeling by the patient’s own biology over time
Dr. Louis Jenis of The Boston Spine Group commented: “A growing number of less invasive procedures are being performed, reducing the impact of surgery on patients. Actifuse MIS will play a key role in the delivery of high quality bone graft to difficult to access sites and help us to achieve our goal of successful fusion. Actifuse MIS gives me the flexibility to respond to varying volume requirements and the ability to place graft precisely where I need it.”